bioMérieux SA
Stock Details
Is it expensive?
Market Cap
8,59B
Trailing P/E Ratio
21,98
Forward P/E Ratio
14,98
PEG Ratio
--
8,25B
7,30
Price-to-Sales (TTM)
2,13
2,11
34,77
Is it profitable?
4,07B
Net Profit Margin (TTM)
9,77%
Gross Profit Margin
0,00%
Diluted EPS (TTM)
3,34
9,54%
Is it growing?
-2,50%
9,00%
Is it risky?
0,54
11,24
461,40M
2,39
Who owns it?
18,66%
66,46%
0,00%
117,99M
40,29M
Does it pay?
4,94%
26,95%
Jun 9, 2026
--
How much cash?
569,80M
788,40M
615,77M
4,83
- Price (EOD)
- 72,85
- Percent Change
- -0,55 (0,75%)
- Previous Close
- 73,40
- Open
- 73,55
- Low
- 72,65
- High
- 74,00
52-Week Range Position (52WRP)
Cheap
Cheap
within its 1-year price range
€72,85
From 52W Low
+7.05%
From 52W High
-43.22%
Today
-0.75%
1Y Change
-39.54%
6M
€104,80
3M
€95,25
1M
€71,05
Today
€72,85
From 52W Low
+7.05%
From 52W High
-43.22%
Today
-0.75%
1Y Change
-39.54%
6M
€104,80
3M
€95,25
1M
€71,05
Today
€72,85
Cheap
within its 1-year price range
€72,85
Multi-Timeframe Analysis (MTA)
Reversal Signal
Short-term price is rising while the longer trend remains negative. In technical analysis this is called a reversal signal. The trend may be turning, but confirmation across more periods is needed before it becomes an uptrend. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+2.5%
3M
-23.5%
6M
-30.5%
1Y
-39.5%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- bioMérieux SA
- Founded
- 1963
- CEO
- Ahmed Khaled El-Hoshy
- Employees
- 14.147
- Fiscal Year End
- Dec 31, 2025
- Address
376 Chemin De l’Orme
Marcy-l'Étoile
MI
69280
France
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.biomerieux.com
Indicators
Operating Cash Flow
788,40M
Net Income
397,50M
Real Earnings
1.98
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
CAC Next 20Index CAC Next 20 - CN20 |
SBF 120Index SBF 120 - PX4 |
Indicators
Operating Cash Flow
788,40M
Net Income
397,50M
Real Earnings
1.98
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
8,59B
Trailing P/E Ratio
21,98
Forward P/E Ratio
14,98
PEG Ratio
--
8,25B
7,30
Price-to-Sales (TTM)
2,13
2,11
34,77
Is it profitable?
4,07B
Net Profit Margin (TTM)
9,77%
Gross Profit Margin
0,00%
Diluted EPS (TTM)
3,34
9,54%
Is it growing?
-2,50%
9,00%
Is it risky?
0,54
11,24
461,40M
2,39
Who owns it?
18,66%
66,46%
0,00%
117,99M
40,29M
Does it pay?
4,94%
26,95%
Jun 9, 2026
--
How much cash?
569,80M
788,40M
615,77M
4,83
- Price (EOD)
- 72,85
- Percent Change
- -0,55 (0,75%)
- Previous Close
- 73,40
- Open
- 73,55
- Low
- 72,65
- High
- 74,00
52-Week Range Position (52WRP)
Cheap
Cheap
within its 1-year price range
€72,85
From 52W Low
+7.05%
From 52W High
-43.22%
Today
-0.75%
1Y Change
-39.54%
6M
€104,80
3M
€95,25
1M
€71,05
Today
€72,85
From 52W Low
+7.05%
From 52W High
-43.22%
Today
-0.75%
1Y Change
-39.54%
6M
€104,80
3M
€95,25
1M
€71,05
Today
€72,85
Cheap
within its 1-year price range
€72,85
Multi-Timeframe Analysis (MTA)
Reversal Signal
Short-term price is rising while the longer trend remains negative. In technical analysis this is called a reversal signal. The trend may be turning, but confirmation across more periods is needed before it becomes an uptrend. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+2.5%
3M
-23.5%
6M
-30.5%
1Y
-39.5%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- bioMérieux SA
- Founded
- 1963
- CEO
- Ahmed Khaled El-Hoshy
- Employees
- 14.147
- Fiscal Year End
- Dec 31, 2025
- Address
376 Chemin De l’Orme
Marcy-l'Étoile
MI
69280
France
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.biomerieux.com
Related Heatmaps
CAC Next 20Index CAC Next 20 - CN20 |
SBF 120Index SBF 120 - PX4 |